| Announce Date | 12/03/2025 |
| EPS Normalized Actual | $3.25 (Beat by $0.39) |
| EPS GAAP Actual | $3.25 (Beat by $0.39) |
| Revenue Actual | $10.259B |
| Revenue Surprise | Beat by $10259M |
| Announce Date | 01/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $3.00238 |
| EPS GAAP Estimate | $3.00238 |
| Revenue Estimate | $10.970172712B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jan 2030 | 17.15 | 11.06 | 16.80412 | 17.83368 | 2 |
| Jan 2030 | 20.89667 | 9.08 | 20.38542 | 21.34262 | 17 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.19 | -0.59735 | 10.259B | 7.94% | -453.31M |
| FQ3 2025 (Jul 2025) | 1.97 | -0.67412 | 10.236B | 8.9% | 182.52M |
| FQ2 2025 (Apr 2025) | 1.61 | 1.61 | 9.829B | 7.08% | 9829M |
| FQ1 2025 (Jan 2025) | 1.78 | 1.78 | 9.993B | 7.06% | 9993M |
| FQ4 2024 (Oct 2024) | 1.58 | 1.58 | 9.444B | 7.67% | 9444M |
| FQ3 2024 (Jul 2024) | 1.48 | 1.48 | 9.325B | 7.74% | 9325M |
| FQ2 2024 (Apr 2024) | 1.58 | 1.58 | 9.133B | 9.7% | 9133M |
| FQ1 2024 (Jan 2024) | 1.47 | 1.47 | 9.287B | -237.59% | 9287M |
FQ4 Announce Date
01/30/2026 (Pre-Market)
Consensus EPS Estimates
3.00238
Consensus Revenue Estimates
10.970172712B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 3.8677 | -- | 3.84 | 3.9015 | 23 |
| FQ4 2027 (Oct 2027) | 3.60847 | -- | 3.59692 | 3.66429 | 23 |
| FQ3 2027 (Jul 2027) | 3.51438 | -- | 3.50313 | 3.56874 | 20 |
| FQ2 2027 (Apr 2027) | 3.29634 | -- | 3.28714 | 3.31755 | 23 |
| FQ1 2027 (Jan 2027) | 3.40395 | -- | 3.35092 | 3.63642 | 16 |
| FQ4 2026 (Oct 2026) | 3.30047 | 33.65 | 3.26642 | 3.34084 | 13 |
| FQ3 2026 (Jul 2026) | 3.20431 | 38.52 | 3.17125 | 3.2435 | 11 |
| FQ2 2026 (Apr 2026) | 3.0925 | 47.94 | 3.0606 | 3.13032 | 13 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Jan 2028) | 13.14B | -- | 13.07B | 13.23B | 20 |
| FQ4 2027 (Oct 2027) | 12.23B | -- | 12.2B | 12.38B | 19 |
| FQ3 2027 (Jul 2027) | 12.03B | -- | 12B | 12.17B | 19 |
| FQ2 2027 (Apr 2027) | 11.7B | -- | 11.68B | 11.76B | 18 |
| FQ1 2027 (Jan 2027) | 12.01B | -- | 11.86B | 12.64B | 17 |
| FQ4 2026 (Oct 2026) | 11.66B | 12.03 | 11.57B | 11.77B | 14 |
| FQ3 2026 (Jul 2026) | 11.53B | 11.22 | 11.44B | 11.64B | 12 |
| FQ2 2026 (Apr 2026) | 11.18B | 12.09 | 11.09B | 11.29B | 14 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | 2.78735 | 2.19 | -0.59735 | -27.28% |
| FQ3 2025 (Jul 2025) | 2.64412 | 1.97 | -0.67412 | -34.22% |
| FQ2 2025 (Apr 2025) | 1.61 | 1.61 | 100% | |
| FQ1 2025 (Jan 2025) | 1.78 | 1.78 | 100% | |
| FQ4 2024 (Oct 2024) | 1.58 | 1.58 | 100% | |
| FQ3 2024 (Jul 2024) | 1.48 | 1.48 | 100% | |
| FQ2 2024 (Apr 2024) | 1.58 | 1.58 | 100% | |
| FQ1 2024 (Jan 2024) | 1.47 | 1.47 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Oct 2025) | $10.71B | $10.26B | $-453.31M | -4.42% |
| FQ3 2025 (Jul 2025) | $10.05B | $10.24B | $182.52M | 1.78% |
| FQ2 2025 (Apr 2025) | $0B | $9.83B | $9829M | 100% |
| FQ1 2025 (Jan 2025) | $0B | $9.99B | $9993M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $9.44B | $9444M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $9.33B | $9325M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $9.13B | $9133M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $9.29B | $9287M | 100% |